Research has been going on for many years on vaccines to prevent HSV-2 infection. An experimental vaccine is currently in clinical trials. At best, this vaccine will be only partly effective in preventing infection. If the research results are positive, it will be at least another 3-4 years before the vaccine is available.

Although various vaccines against herpes have been studied, we have no indication of when they will be available. Some of the vaccines have demonstrated positive effects in certain groups of people (e.g., women without herpes infection); however, research in this area is ongoing. Antiviral agents significantly reduce the number of genital herpes outbreaks when taken daily for a prolonged period of time (suppressive therapy). However, if you stop taking antiviral medication, outbreaks can resume.

A.    Yes. Since chickenpox and shingles are caused by the same virus (varicella zoster), the shingles vaccine is the chickenpox vaccine

Influenza vaccine cannot prevent avian influenza as the vaccine was meant for human influenza. However, the vaccine can help reduce the chance of complications and hospitalization from human influenza; hence it is recommended for the elderly and patients with chronic illnesses. Influenza vaccine can also reduce the chance of genetic re-assortment and subsequent emergence of influenza strain with pandemic potential.

In 2006, the Food and Drug Administration (FDA) approved a vaccine that prevents two types of HPV (HPV 16 and 18) that cause 70% of all cervical cancers. The vaccine also prevents two types of HPV (HPV 6 and 11) that cause 90% of all genital warts.

The MMR vaccine prevents measles and two other viral diseases - mumps and rubella. These three vaccines are safe given together. MMR is a attenuated (weakened) live virus vaccine. This means that after injection, the viruses grows, and causes a harmless infection in the vaccinated person with very few, if any symptoms. The person's immune system fights the infection caused by these weakened viruses and immunity develops which lasts throughout that person's life.

NO! There are many vaccines now in clinical study, however at this time, none have been tested on humans and it may be years before a viable vaccine is possible.

There are no commercial supplies of vaccine against pandemic influenza virus because the specific pandemic strain is not known in advance. It is impossible to develop a perfect match vaccine until a new influenza virus has shifted to human-to-human transmission and that strain has been identified and characterized so that a vaccine can be developed.

Overall, approximately 72,000 healthy infants were studied worldwide in randomized placebo-controlled studies to look at both the safety of RotaTeq® and how well it works. The data showing how well RotaTeq® prevents rotavirus gastroenteritis comes from almost 7,000 of these infants from the United States and Finland. In these studies, RotaTeq® prevented 74 percent of all rotavirus gastroenteritis cases and 98 percent of the severe cases.

Yes, a safe and effective vaccine is available. The vaccine is eighty-five percent to one hundred percent effective in preventing four kinds of bacteria (serogroups A, C, Y, W-135) that cause about seventy percent of the disease in the United States. The vaccine is safe, with mild and infrequent side effects, such as redness and pain at the injection site lasting up to two days. After vaccination, immunity develops within seven to ten days remains effective for approximately three to five years.

present there is no vaccine for bird flu. It will take about 4 months to produce a vaccine that can be available in the market. Influenza vaccine is available but it will not protect against the bird flu. This vaccine is different from year to year. The change becomes necessary since influenza viruses tend to undergo frequent and permanent changes.

Yes. Sometimes, people with recurrent genital herpes need or want suppressive therapy, which means taking medicine daily for up to 1 year to lessen the number of outbreaks. This may be because they experience many outbreaks (e.g., more than 6 per year). For many people, however, treating their genital herpes outbreak for a short period of time as soon as they feel the warning sensations (episodic treatment) is appropriate and even preferred in some cases.

There have been claims that certain modified-live Rhino vaccines protect horses from the neurological strain of the Equine Herpesvirus-1 that has recently killed several horses. According the California Department of Agriculture as well as UC Davis, these claims are false. There is no product on the market that is labeled to protect against this neurological strain of Equine Herpesvirus-1. We currently vaccinate with the Ft.

The anthrax vaccine is not currently available to the general public. The vaccine is only available to the military because of the risk they may encounter overseas. Even in light of the current situation, the risk of exposure to anthrax by the general public is considered to be low. Exposure to anthrax can be treated with early interventions. Anthrax does not spread from person to person.

How long a new vaccine protects people is never known when the vaccine is first introduced. Research is being done to find out how long protection against HPV will last, and if a booster vaccine will be needed.

Until the virus has been identified, it is not possible toprepare a vaccine against a pandemic strain of influenza virus. Once the virusis identified, the vaccine will take about four to six months to produce.Therefore, depending on the gap between the two waves of infection a vaccineshould be available for the second wave of infection.

Too much sun can trigger a cold sore if the virus is already in your system. So yes, using sunscreen can help to prevent a cold sore. Cold sores are common. But though you can't cure or prevent cold sores, you can take steps to reduce their frequency and to limit the duration of an occurrence. If you have ever had a cold sore, then the virus is in your system and lies dormant until something triggers it.

People with herpes think there is a 100 per cent probability that they will pass their condition onto someone. But if a person is taking their medication and practising safe sex, their risk of passing herpes onto another is low. It's all about learning how to manage the condition." - Dr.

Has a moderate to severe illness. If this is the case, the person may receive the vaccine when feeling better.